Clinical research

Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction

EuroIntervention 2012;8:71-78 publish online ahead of print February 2012. DOI: 10.4244/EIJV8I1A12

Pascal Vranckx
Pascal Vranckx1, MD; Gianluca Campo2, MD; Maurizio Anselmi3, MD; Leonardo Bolognese4, MD; Salvatore Colangelo5, MD; Giuseppe Biondi-Zoccai6, MD; Raul Moreno7, MD; Tommaso Piva8, MD; Luca Favero9, MD; Francesco Prati10, MD, PhD; Marco Nazzaro11, MD, PhD; José F. Díaz Fernández12, MD; Roberto Ferrari2, MD, PhD; Marco Valgimigli2*, MD, PhD; for the Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators
1. Hartcentrum, Hasselt, Belgium; 2. University of Ferrara, Ferrara, Italy and Cardiovascular Research Center, Salvatore Maugeri Foundation, IRCCS, Gussago (BS), Italy; 3. Department of Biomedical and Surgical Sciences, Cardiology Secti

Aims: While bleeding in patients with STEMI undergoing primary percutaneous coronary intervention (pPCI) is known to be associated with poor out

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

haemorrhageaccess-sitepercutaneous coronary interventionacute myocardial infarction
Read next article
Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience

Latest news